Peaked at #3 Now #4
GPT-Rosalind Drug Discovery Breakthrough
OpenAI says GPT-Rosalind surfaced a drug-discovery lead: restoring cholesterol transport may protect neurons from degeneration.
Key points
- OpenAI says GPT-Rosalind surfaced a new drug discovery lead: whether restoring cholesterol transport could protect neurons from degeneration.
- In mouse-brain data, disrupting DCTN1 increased expression of genes involved in making cholesterol; GPT-Rosalind suggested cholesterol may not be reaching where neurons need it.
- With @perturbai_tx and @scrippsresearch, thousands of GPT-Rosalind agents connected gene-expression results from millions of mouse brain cells with scientific literature in 32 minutes.
- OpenAI says it is now expanding this collaboration to identify new drug targets.
Key points and the reaction summary are written by AI from the posts on this page. Check the original post. How we use AI
Original post
Top replies on X
Reaction on X: Replies are largely enthusiastic, with one user saying AI can analyze data that would take scientists close to a year in minutes and calling it a new era, while another called the thousands-of-agents setup clean. A few replies questioned the basis of the model, asking which model Rosalind is based on, and said the biology went over their head. The original poster added that in the same mouse-brain dataset, GPT-Rosalind found a possible clue to why TSC2 mutations tend to cause more severe tuberous sclerosis than TSC1 mutations.
Sign in to see 5 top replies from X
From @OpenAI, @IterIntellectus, @repojournal and others. Spam removed, with English and Chinese translations.
Discussion 0
Sign up Sign in to join the discussion
No comments yet. Start the conversation.